Vocal nodules Vocal polyps
Conditions
Interventions
Performing microsurgical laryngeal procedures that are completed in a short period of time without discontinuation of low-dose pills in the 4 weeks prior to the perioperative period. This is an inter
Sponsors
International University of Health and Welfare
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Patients who visit Tokyo Voice Center on or after the date of approval and are scheduled to undergo microlaryngeal surgery under general anesthesia with a diagnosis of vocal nodule or vocal polyp (1) Patients taking low-dose pills who are scheduled to undergo microlaryngeal surgery under general anesthesia at Tokyo Voice Center on or after the date of approval (2) Patients who are able to obtain written consent to participate in the research of their own free will. (3) Patients who are between 18 and 50 years of age at the time of consent (4) Gender: Female
Exclusion criteria
Exclusion criteria: (1) Those with laryngeal diseases other than vocal nodules or vocal polyps (2) Patients with serious renal, cardiovascular, hematological (hereditary blood coagulation abnormalities), hepatic, and respiratory diseases (3) Patients with cancer and those undergoing anticancer drug treatment (4) Women who are pregnant or may become pregnant (5) Patients with cognitive impairment (6) Patients with a history of hypersensitivity to this drug (trafermin) (7) Patients who have participated in other clinical trials or clinical studies within 12 weeks prior to obtaining consent (8) Patients with a history of alcohol dependence or drug abuse (9) Undergraduate and graduate students of the University (10) Other patients deemed inappropriate for this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of adverse events | — |
Countries
Japan
Contacts
Public ContactTomohiro Hasegawa
International University of Health and Welfare Tokyo Voice Center
Outcome results
None listed